Genetic Variants in Sulfonylurea Targets Affect Parkinson's Disease Risk: A Two-Sample Mendelian Randomization Study

Mov Disord. 2023 Apr;38(4):703-705. doi: 10.1002/mds.29341. Epub 2023 Feb 13.

Authors

N Ahmad Aziz^{1

2}, Ullrich Wüllner^{1

2

3}

Affiliations

¹ German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.
² Department of Neurology, University Hospital Bonn, Bonn, Germany.
³ Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Bonn, Germany.

PMID: 36782054
DOI: 10.1002/mds.29341

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Disease Susceptibility
Genetic Variation / genetics
Genome-Wide Association Study
Humans
Mendelian Randomization Analysis
Parkinson Disease* / drug therapy
Parkinson Disease* / genetics
Polymorphism, Single Nucleotide / genetics
Risk Factors

Grants and funding